Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Frailty check could flag risky meds in seniors at ER

NCT ID NCT07282379

Knowledge-focused Sponsor: Pharmacie des Hopitaux de l'Est Lemanique Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will check if a simple frailty score (ISAR) can predict medication problems in elderly patients visiting the emergency department. Researchers will review the medical records of 300 patients aged 75 and older, looking for inappropriate prescriptions and dangerous drug interactions. The goal is to give pharmacists a quick way to prioritize which patients need a medication review, without changing any care during the study.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could give emergency departments a simple tool to identify which elderly patients need a pharmacist's medication review most urgently.
What could go wrong
This is an observational study, not a treatment trial. It only looks for a link between frailty and medication issues, so it won't directly improve patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of all geriatric patients residing in the area of the Riviera-Chablais Hospital (Rennaz, Canton of Vaud, Switzerland). This hospital cares for nearly 200,000 people and its adult emergency department receives 35,000 patients per year (20% of whom are aged 75 and over).

Ages

75 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged ≥ 75 years admitted to the adult emergency department * Patients able to give informed consent as documented by signature or a therapeutic representative, if applicable . Exclusion Criteria: * Patients initially admitted to the emergency resuscitation room. * Patients admitted to the minor accidents and emergencies room. * Patients admitted to the stroke unit, as they just pass through the emergency department to directly proceed to the CT-scanner. * Missing data for proper file analysis (e.g., missing usual home medication) * Patient's inability to sign consent and no therapeutic representative available * Patient's refusal to sign consent * Emergency physician's refusal to include patient for any reason.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Drug drug interaction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Emergencies Frailty substance abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Drug drug interaction Elderly Emergency department visit Frailty Inappropriate drug use

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hôpital Riviera-Chablais (Vaud-Valais), service des urgences

    Rennaz, Canton of Vaud, 1847, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.